Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

64
BRITISH COLUMBIA
The clinical trials unit primarily conducts Phases II, III, and IV clinical trials. Studies include populations
from newborn to the elderly. Enrollments range in size from 25 to 300 subjects per study.
The facility has five Principal Investigators as listed below, and eight Associate Investigators. Their details
can be found in Appendix 6.
• Bettinger, Julie • Sauve, Laura
• Dobson, Simon • Scheifele, David (Director)
• Kollmann, Tobias
The Vaccine Evaluation Centre functions as a cooperative with investigators sharing a pool of staff and
expertise. Staffing of the Centre is as follows:
Study Nurses 1 Data Managers/Coordinators
Research Assistants
3
Pharmacy
Staff
Laboratory
Staff
Admin. Other
10 2 3 0* 0 4** 3***
* Dispensing of vaccines not required.
** 1 Finance Manager, 2 Field Nursing Managers, 1 secretary
*** 1 Statistician, 2 programmers
Quality control procedures are based on Health Canada and FDA regulations. The Unit has extensive
SOPs covering multiple aspects of clinical trials, data management, laboratory practices and staff training.
Contact:
Bjornson, Gordean. Tel: 604-875-2422. gbjornson@cw.bc.ca.
Women & Family HIV Centre
The Women and Family HIV Centre is a Provincial resource that provides medical care to women,
children and youth living with HIV disease in B.C. (no URL). It is jointly sponsored by the Women’s
Health Centre and BCCH. The centre has an important priority of preventing the transmission of HIV
from pregnant women to their infants by coordinating a Provincial program of treating the mothers
and their infants with antiretroviral medications. These infants and all HIV infected children and youth
less than 18 years of age receive medical care at the centre (see www.cfri.ca/our_research/researchers/search_researchers/researcher_detail.asp?ID=41;
http://gateway.nlm.nih.gov/MeetingAbstracts/
ma?f=102209450.html). The centre is active in clinical research, including novel treatments, vaccines,
and diagnostic/ prognostic biomarkers. It is also part of the national surveillance program of the Canadian
Perinatal HIV database, which is reported annually by Public Health Agency of Canada.
Investigators include the following whose details can be found in Appendix 6:
• Burdge, David
• Forbes, John (Jack).
Contact:
Forbes, John (Jack). Medical Director. Tel: 604-875-2212. jforbes@cw.bc.ca.